# A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

> **NCT07116031** · PHASE2 · RECRUITING · sponsor: **Sanofi** · enrollment: 37 (estimated)

## Conditions studied

- Chronic Graft Versus Host Disease

## Interventions

- **DRUG:** Belumosudil
- **DRUG:** Belumosudil

## Key facts

- **NCT ID:** NCT07116031
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-02
- **Primary completion:** 2031-02-28
- **Final completion:** 2031-02-28
- **Target enrollment:** 37 (ESTIMATED)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07116031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07116031, "A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07116031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*